However, low levels of IL-5 have been associated with disease progression in HIV infection [84,85], and while GM-CSF has been suggested as a possible treatment for neutropenia in AIDS patients, increased infiltration of inflammatory mediators in some patients is alarming [86]. Here, CSF2 is linked to neutropenia.